NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
10.18
-0.54 (-5.04%)
At close: May 7, 2026, 4:00 PM EDT
10.18
0.00 (0.00%)
After-hours: May 7, 2026, 4:04 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $36.72 million as of May 7, 2026. Its market cap has increased by 211.65% in one year.
Market Cap
36.72M
Enterprise Value
59.91K
1-Year Change
211.65%
Ranking
Category
Stock Price
$10.18
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $36.72M, a decrease of -91.59%. That is a compound annual growth rate of -29.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 36.72M | -26.17% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 39.50M |
| Mereo BioPharma Group | 38.31M |
| Actinium Pharmaceuticals | 38.03M |
| INmune Bio | 38.02M |
| Aligos Therapeutics | 37.31M |
| Palatin Technologies | 37.00M |
| Veru Inc. | 36.27M |
| CervoMed | 35.18M |